Immunodiagnosis of Trypanosoma cruzi (Chagas' disease) infection in naturally infected dogs

被引:33
|
作者
Luricella, MA
Castanera, MB
Gurtler, RE
Segura, EL
机构
[1] Inst Nacl Parasitol Dr Mario Fatala Chaben, RA-1063 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ciencias Biol, RA-1428 Buenos Aires, DF, Argentina
[3] Adm Nacl Labs, RA-1281 Buenos Aires, DF, Argentina
[4] Inst Salud Dr Carlos G Malbran, RA-1281 Buenos Aires, DF, Argentina
来源
MEMORIAS DO INSTITUTO OSWALDO CRUZ | 1998年 / 93卷 / 04期
关键词
Trypanosoma cruzi; serology; chronic infection; dogs; surveillance;
D O I
10.1590/S0074-02761998000400016
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
This study reports on the standardization of an enzyme-linked immunosorbent assay (ELISA) for detecting specific antibodies anti-Trypanosoma cruzi in naturally infected dogs. Sera from 182 mongrel dogs of all ages residing in four rural villages in Santiago del Estero, Argentina, were collected in November 1994 and preserved in buffered neutral glycerin. All sera were tested by indirect hemagglutination test (IHAT), indirect immunofluorescence test (IFAT), and ELISA using the flagellar fraction of T. cruzi as antigen. Dog sera from an area without vectorial transmission were used to calculate ELISA specificity and cut-off value. Eighty-six percent of sera had concordant results for all tests. All sera reactive for IHAT and IFAT were also reactive for ELISA, except in one case. Sera tested by ELISA when diluted 1:200 allowed a clearer division between non-reactive and reactive sera than when 1:100 with greater agreement among serologic techniques. The specificity of ELISA was 96.2%. Among 34 adult dogs with a positive xenodiagnosis, sensitivity was 94% both for ELISA and IFAT. ELISA is the first choice for screening purposes and one of the pair of techniques recommended for diagnostic studies in dog populations.
引用
下载
收藏
页码:501 / 507
页数:7
相关论文
共 50 条
  • [31] Trypanosoma cruzi and Chagas' Disease in the United States
    Bern, Caryn
    Kjos, Sonia
    Yabsley, Michael J.
    Montgomery, Susan P.
    CLINICAL MICROBIOLOGY REVIEWS, 2011, 24 (04) : 655 - 681
  • [32] Placenta,Trypanosoma cruzi, and Congenital Chagas Disease
    Carlier, Yves
    Schijman, Alejandro G.
    Kemmerling, Ulrike
    CURRENT TROPICAL MEDICINE REPORTS, 2020, 7 (04) : 172 - 182
  • [33] Placenta, Trypanosoma cruzi, and Congenital Chagas Disease
    Yves Carlier
    Alejandro G. Schijman
    Ulrike Kemmerling
    Current Tropical Medicine Reports, 2020, 7 : 172 - 182
  • [34] Mechanisms of Trypanosoma cruzi persistence in Chagas disease
    Nagajyothi, Fnu
    Machado, Fabiana S.
    Burleigh, Barbara A.
    Jelicks, Linda A.
    Scherer, Philipp E.
    Mukherjee, Shankar
    Lisanti, Michael P.
    Weiss, Louis M.
    Garg, Nisha J.
    Tanowitz, Herbert B.
    CELLULAR MICROBIOLOGY, 2012, 14 (05) : 634 - 643
  • [35] Immunodiagnosis of Chagas disease: Synthesis of three latex-protein complexes containing different antigens of Trypanosoma cruzi
    Gonzalez, Veronica D. G.
    Garcia, Valeria S.
    Vega, Jorge R.
    Marcipar, Ivan S.
    Meira, Gregorio R.
    Gugliotta, Luis M.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2010, 77 (01) : 12 - 17
  • [38] Biogeography and Trypanosoma cruzi Infection Prevalence of Chagas Disease Vectors in Texas, USA
    Kjos, Sonia A.
    Snowden, Karen F.
    Olson, Jimmy K.
    VECTOR-BORNE AND ZOONOTIC DISEASES, 2009, 9 (01) : 41 - 49
  • [39] CONGENITAL CHAGAS DISEASE - EFFECT OF TRYPANOSOMA CRUZI INFECTION ON EMBRYOGENY IN GRAVID MICE
    WERNER, H
    EGGER, I
    ZEITSCHRIFT FUR TROPENMEDIZIN UND PARASITOLOGIE, 1971, 22 (03): : 224 - &
  • [40] Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)
    Reyes, P. A.
    Vallejo, M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (04):